CPT code 0252U: Fetal DNA analysis, short tandem-repeat comparison2026 Medicare lab fee · Clinical Laboratory Fee Schedule
Short tandem-repeat comparative analysis of fetal DNA from products of conception reports chromosome status, including euploidy and specified abnormalities.
Medicare pays $759.05 for 0252U under the 2026 Clinical Laboratory Fee Schedule: one national amount, the same in every state and setting.
Medicare lab fee · CLFS 2026 Q4
National CLFS amount
$759.05
In effect since Jan 1, 2026. The same amount in every state, payment locality and setting.
- Geographic adjustment
- None
- Office vs facility
- Same
- Since 2023
- Unchanged
- CMS updates
- Quarterly
Medicare pays the lesser of the lab’s charge and this amount. Patients usually owe no Part B deductible or coinsurance for covered clinical lab tests.
On this page 8 sections
What 0252U covers
0252U identifies a short tandem-repeat comparative analysis of fetal DNA obtained from products of conception. The reported result may classify findings as euploidy, monosomy, trisomy, partial deletion or duplication, mosaicism, or segmental aneuploidy. This is a molecular analysis of conception tissue, not a maternal blood screening test.
Report 0252U for the described fetal DNA analysis. Medicare pays the code only under the Clinical Laboratory Fee Schedule, with one national amount applying in every state and locality and no geographic or office-versus-facility adjustment. The 2026 national CLFS amount is $759.05, unchanged from 2023 through 2026. There is no separate physician fee schedule payment for this code.
This summary was written with AI assistance from CMS Clinical Laboratory Fee Schedule data. Amounts on this page come directly from CMS files.
How Medicare pays 0252U
Clinical lab tests aren’t priced like physician services. They’re paid from their own fee schedule, with its own rules. See the whole lab fee schedule.
One national amount
CMS sets a single Clinical Laboratory Fee Schedule amount for 0252U. There’s no geographic (GPCI) adjustment, so it pays the same in every state and payment locality.
No office or facility rate
Lab tests aren’t built from relative value units, so there’s no office and facility split: the place of service doesn’t change the CLFS amount.
Updated every quarter
CMS republishes the CLFS each quarter. New tests, often proprietary laboratory analyses (PLA codes), join during the year; existing amounts are updated each January.
Not on the physician fee schedule
The physician fee schedule doesn’t list 0252U: Medicare pays the test only from the CLFS.
0252U on the lab fee schedule since 2021
0252U · CLFS 2026 Q4 (current)
$759.05
Unchanged since Jan 1, 2023
Every change on file
- Jan 1, 2023 · CLFS 2023 Q1MAC-priced → $759.05
22 quarterly CLFS releases on file, first CLFS 2021 Q3. A code missing from a quarter wasn’t on that release.
0252U compared with similar tests
- 88262Chromosome analysis15–20 cells, two karyotypes$125.49
- 88262 is conventional cytogenetic chromosome analysis. 0252U is a fetal DNA short tandem-repeat comparative analysis of products of conception.
- 81228Chromosomal microarrayCGH copy-number analysis$900.00
- 81228 describes genome-wide copy-number microarray analysis. 0252U uses short tandem-repeat comparative analysis of fetal DNA.
0252U billing questions
What specimen is associated with 0252U?
The analysis uses fetal DNA from products of conception. It is not a maternal blood screening test.
What chromosome findings can the report identify?
Reported categories include euploidy, monosomy, trisomy, partial deletions or duplications, mosaicism, and segmental aneuploidy.
How does 0252U differ from 88262?
0252U is a fetal DNA short tandem-repeat comparative analysis. 88262 is conventional cytogenetic chromosome analysis.
Which Medicare payment schedule applies?
Medicare pays 0252U only through the CLFS. One national amount applies across localities, without an office-versus-facility adjustment.
How does 0252U differ from 81228?
0252U uses short tandem-repeat comparison of fetal DNA. 81228 describes genome-wide copy-number microarray analysis.
Where this amount comes from
FeeBase reads lab amounts directly from the CMS Clinical Laboratory Fee Schedule file for the quarter: one row per code, with its payment indicator and national amount. Contractor-priced tests are labeled, never given a made-up amount. Amounts are Medicare payment limits, not a patient’s bill or a commercial rate.
CMS CLFS 2026 Q4 · effective Oct 1, 2026 through the day before Jan 1, 2027
Show the CMS file line behind this amount
Fee sheets · Coming soon
Put 0252U and the rest of your codes on one sheet
Your codes at your locality, with payer contracts beside Medicare.
Join the waitlist